Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001588092 | SCV001823441 | likely benign | not provided | 2020-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001588092 | SCV002218212 | uncertain significance | not provided | 2024-11-02 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 9 of the FBLN5 gene. It does not directly change the encoded amino acid sequence of the FBLN5 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs762189469, gnomAD 0.03%). This variant has been observed in individual(s) with Charcot-Marie-Tooth disease (internal data). ClinVar contains an entry for this variant (Variation ID: 1217419). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV001588092 | SCV005873995 | uncertain significance | not provided | 2024-09-24 | criteria provided, single submitter | clinical testing | No Rules Apply |